Efficacy of Different Traditional Chinese Medicine Interventions for Adenomyosis: A Network Meta-Analysis
OA: closed
CC0
Abstract
Background This network meta-analysis aimed to explore the impact of different traditional Chinese medicine (TCM) interventions for adenomyosis and assess the effectiveness differences among various TCM therapies. Methods Eight databases were searched to July 31, 2025, for randomized controlled trials (RCTs). Outcomes were visual analog scale (VAS) score, dysmenorrhea score, uterine volume, serum cancer antigen 125 (CA125) and Pictorial Blood Loss Assessment Chart (PBAC) score. Heterogeneity was quantified for every direct comparison, publication bias assessed with Egger’s test, pre-specified sensitivity analyses performed, and certainty graded with GRADE in Confidence in Network Meta-Analysis. Results Fifty-two RCTs (4,424 patients) were included. Every trial compared one TCM intervention with Western medicine, so the network had a star configuration and no closed loop, and all TCM-versus-TCM estimates were indirect. TCM therapies outperformed Western medicine across most, but not all, comparisons. Electroacupuncture (surface under the cumulative ranking curve [SUCRA] 93%) and acupoint catgut embedding (91.6%) ranked highest for VAS yet were statistically indistinguishable (standardized mean difference –0.01, 95% confidence interval –1.90 to 1.88); TCM combined therapy ranked first for uterine volume, CA125, and PBAC. For most outcomes the leading intervention did not differ significantly from those ranked below it. Certainty was low or very low for 121 of 128 comparisons (94.5%), moderate for 7, and high for none. Conclusion SUCRA values reflect ranking probabilities only and do not establish statistical superiority. As all between-TCM comparisons were indirect and certainty was predominantly low or very low, these rankings are exploratory, and head-to-head trials are required before any intervention can be recommended as optimal.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Acupuncture for dysmenorrhea of adenomyosis: A randomized controlled trial 针刺治疗子宫腺肌病痛经:随机对照试验 via openalex
- Bioinformatic analysis and machine learning to identify the diagnostic biomarkers and immune infiltration in adenomyosis via openalex
- [Chinese experts' consensus on diagnosis and treatment of adenomyosis] via openalex
- Guideline No. 437: Diagnosis and Management of Adenomyosis via openalex
- Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis via openalex
- Pregnancy outcomes and influencing factors following high-intensity focused ultrasound treatment for adenomyosis: a single-center retrospective study via openalex
- The etiology differs regards to the locations of the lesion: a clinical experience of 1350 patients with adenomyosis confirmed by postoperative pathology via openalex
- Treatment ideas of acupuncture and moxibustion for adenomyosis based on "etiology, location, nature and development of disease" via openalex
- W2098923148 via openalex
- W4294607903 via openalex
- W2000770184 via openalex
- W4319869768 via openalex
- W1982586488 via openalex
- W4388127664 via openalex
- W4388662155 via openalex
- W4395464502 via openalex
- W4405867251 via openalex
- W4408536806 via openalex
- W4414091616 via openalex
- W4414701741 via openalex
- W4414751817 via openalex
- W2786697307 via openalex
- W1617328014 via openalex
- W4214566944 via openalex
Source provenance
- openalex
- last seen: 2026-11-19T06:04:33.792782+00:00
License: CC0
· commercial use OK